<DOC>
	<DOCNO>NCT00122746</DOCNO>
	<brief_summary>The researcher plan : - To undertake clinical study radiotherapy without administration chemotherapeutic agent cisplatin , know radiosensitizer ; - To perform pre-clinical study radiosensitivity human fibroblasts cervical cancer cell line culture , without addition various HIV proteins protease inhibitor , order determine extent cellular radiosensitizing property molecules ; - To develop strategy sensitize tumour cell radiation , specifically down-regulating specific viral protein know factor associate resistance radiotherapy .</brief_summary>
	<brief_title>Clinical Experimental Studies Improve Radiotherapy Outcome AIDS Cancer Patients</brief_title>
	<detailed_description>Clinical study address question whether radiotherapy plus weekly cisplatin offer advantage radiotherapy give alone AIDS patient cervix cancer . External beam radiotherapy use 50 Gy 25 daily fraction ( last interim analysis , October 2005 ) suggest lower total dose 46 Gy 23 daily fraction ) . Brachytherapy component specify either 30 Gy LDR single fraction 3 fraction 8 Gy use HDR . Cisplatin administer weekly dose 30 mg/sqm .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Cancer cervix AIDS Unable give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Cervical Cancer</keyword>
	<keyword>AIDS</keyword>
	<keyword>External Beam Radiotherapy</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>Cisplatin</keyword>
</DOC>